Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

RNL Europe

2006 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of stem cells. The company develops stem cell drugs for selected medical applications as well as for research in Germany.

Formerly Known As
Pharmicell Europe
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare
Acquirer
RNL Bio Company
Primary Office
  • Friedrichstr. 147
  • 10117 Berlin
  • Germany

RNL Europe Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore RNL Europe‘s full profile, request access.

Request full access to PitchBook